Hematological toxicity of cyclin-dependent kinase 4/6 inhibitors in patients with breast cancer: a network meta-analysis and pharmacovigilance study
2024 · Expert Opinion on Drug Safety · 8 citations
https://doi.org/10.1080/14740338.2024.2348566
UNSW Sydney(AU)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
5
Papers
220
Citations
4
h-index
4
i10-index
Yinghui Tong is an academic researcher from UNSW Sydney. The author has contributed to research in topics: Traditional Chinese Medicine Analysis & Mesenchymal stem cell research & Criminal Justice and Corrections Analysis. The author has an h-index of 4, co-authored 5 publications.
ORCID: 0009-0008-6793-1025https://doi.org/10.1080/14740338.2024.2348566
https://doi.org/10.1007/s40122-021-00342-0
Click to start Chat